Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
K TamuraJapan Febrile Neutropenia Study Group

Abstract

A multicenter open randomized trial was conducted to compare cefepime monotherapy with cefepime/amikacin combination (dual) therapy in treating febrile neutropenic patients with hematologic disorders. Among the 189 evaluable patients, 5.8% had microbiologically and 10.6% had clinically documented infections. Excellent response was seen in 32.6% and 45.7% of monotherapy and dual therapy recipients, respectively, at day 3 (P=.065). At day 3, patients with neutrophil counts of <500/ mu L receiving dual therapy had a better response than did those receiving monotherapy (45% vs. 27.6%; P=.024). The same was true for patients with leukemia. Adverse events were minimal, and early death was observed in 7 patients in the dual therapy group and 5 patients in the monotherapy group. Overall, cefepime monotherapy is as effective as dual therapy for the initial treatment of febrile neutropenic patients. Further study is warranted for patients with severe neutropenia and leukemia who may benefit from dual therapy.

Citations

Mar 3, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L GómezJ Garau
May 20, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S HashinoM Asaka
Jan 8, 2014·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Emine BinnetoğluHacer Sen
Jul 14, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Juan J Picazo
Jul 14, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K Ohyashiki
Jul 14, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K Tamura
Nov 14, 2006·Journal of Paediatrics and Child Health·Hany AriffinWan Ariffin Abdullah
Apr 1, 2014·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hiroshi SaitoUNKNOWN Central Japan Lung Study Group
Sep 13, 2006·Leukemia & Lymphoma·Hitoshi MatsuokaUNKNOWN Kyushu Hematology Organization for Treatment (K-HOT) Study Group, Fukuoka, Japan
Jul 11, 2008·Expert Opinion on Drug Safety·Lorenzo Drago, Elena De Vecchi
Feb 5, 2011·International Journal of Antimicrobial Agents·Ronit MarcusLeonard Leibovici
Feb 5, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Masaki FujitaUNKNOWN Lung Oncology Group in Kyushu (LOGIK)
Jan 29, 2011·Internal Medicine Journal·L J WorthUNKNOWN Australian Consensus Guidelines 2011 Steering Committee
Jan 29, 2011·Internal Medicine Journal·C S TamUNKNOWN Australian Consensus Guidelines 2011 Steering Committee
Jul 5, 2015·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Kazuo TamuraMasahiro Saito
Jul 6, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yasunori NakagawaAkio Urabe
May 18, 2010·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Yong ChongTomohiko Kamimura
Jan 16, 2013·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Takahiko YasudaTomoki Naoe
May 18, 2016·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hideo KohHirohisa Nakamae
Sep 2, 2016·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hideo KohHirohisa Nakamae
Jul 1, 2011·The Korean Journal of Internal Medicine·Dong-Gun LeeJung-Hyun Choi
Jul 3, 2013·The Cochrane Database of Systematic Reviews·Mical PaulLeonard Leibovici
Dec 16, 2006·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Kazuo Tamura
Aug 14, 2019·International Journal of Clinical Oncology·Akiko OtaYuichi Ando

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
K Ohyashiki
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
A Del FaveroGruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Infection Program
© 2022 Meta ULC. All rights reserved